NCT06308861 - Phase 1 to Investigate Safety, Tolerability, PK/PK of J2H-1702 in Healthy Males | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

June 25, 2021

Study Completion Date

July 13, 2021

Conditions

Non-alcoholic Steatohepatitis

Interventions

DRUG

Single administration Amg dose Group

Orally, Amg tablet single administration

DRUG

Single administration Bmg dose Group

Orally, Bmg tablet single administration

DRUG

Single administration Cmg dose Group

Orally, Cmg tablet single administration

DRUG

Single administration Dmg dose Group

Orally, Dmg tablet single administration

DRUG

Single administration Emg dose Group

Orally, Emg tablet single administration

DRUG

Single administration Amg dose Group-Placebo

Orally, Placebo Amg tablet, single administration

DRUG

Single administration Bmg dose Group-Placebo

Orally, Placebo Bmg tablet, single administration

DRUG

Single administration Cmg dose Group-Placebo

Orally, Placebo Cmg tablet, single administration

DRUG

Single administration Dmg dose Group-Placebo

Orally, Placebo Dmg tablet, single administration

DRUG

Single administration Emg dose Group-Placebo

Orally, Placebo Emg tablet, single administration

DRUG

Multiple administration Amg dose group

Orally, Amg 1 tablet, once a day for 3 days, multiple administration

DRUG

Multiple administration Bmg dose group

Orally, Bmg 1 tablet, once a day for 3 days, multiple administration

DRUG

Multiple administration Cmg dose group

Orally, Cmg 1 tablet, once a day for 3 days, multiple administration

DRUG

Multiple administration Dmg dose group

Orally, Dmg 1 tablet, once a day for 3 days, multiple administration

DRUG

Multiple administration Emg dose group

Orally, Emg 1 tablet, once a day for 3 days, multiple administration

DRUG

Multiple administration Amg dose group - Placebo

Orally, Placebo Amg 1 tablet, once a day for 3 days, multiple administration

DRUG

Multiple administration Bmg dose group - Placebo

Orally, Placebo Bmg 1 tablet, once a day for 3 days, multiple administration

DRUG

Multiple administration Cmg dose group - Placebo

Orally, Placebo Cmg 1 tablet, once a day for 3 days, multiple administration

DRUG

Multiple administration Dmg dose group - Placebo

Orally, Placebo Dmg 1 tablet, once a day for 3 days, multiple administration

DRUG

Multiple administration Emg dose group - Placebo

Orally, Placebo Emg 1 tablet, once a day for 3 days, multiple administration

Trial Locations (1)

16684

J2H Biotech, Suwon